Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives

Giroux Leprieur E, Fallet V, Cadranel J, Wislez M

Lung Cancer: Targets and Therapy 2016, 7:83-90

Published Date: 17 June 2016